Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study. [electronic resource]
Producer: 20071220Description: 5465-70 p. digitalISSN:- 1007-9327
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Hepatocellular -- complications
- Chemotherapy, Cancer, Regional Perfusion
- Epirubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intra-Arterial
- Kaplan-Meier Estimate
- Liver Neoplasms -- complications
- Male
- Middle Aged
- Neoplasm Staging
- Pilot Projects
- Portal Vein -- pathology
- Prospective Studies
- Severity of Illness Index
- Tablets, Enteric-Coated
- Tegafur -- administration & dosage
- Time Factors
- Treatment Outcome
- Uracil -- administration & dosage
- Venous Thrombosis -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.